XML 62 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net income including noncontrolling interests $ 214,118 $ 129,685
Loss from discontinued operations 0 2,482
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 41,567 31,925
Share-based compensation expense related to equity classified awards 16,089 13,839
Amortization and write-off of program rights 343,161 291,467
Amortization of deferred carriage fees 8,009 5,501
Unrealized foreign currency transaction (gain) (8,345) (1,338)
Unrealized loss (gain) on derivative contracts, net 791 (1,038)
Amortization of deferred financing costs and discounts on indebtedness 4,476 4,205
Bad debt expense 1,228 1,095
Deferred income taxes 10,069 5,300
Excess tax benefits from share-based compensation arrangements (4,038) (4,708)
Other, net (246) (339)
Changes in assets and liabilities:    
Accounts receivable, trade (18,182) (4,326)
Amounts due from related parties, net 127 891
Prepaid expenses and other assets (15,359) 35,989
Program rights and obligations, net (412,205) (336,284)
Income taxes payable 2,696 11,992
Deferred revenue 33,779 19,867
Deferred carriage fees, net (17,138) (13,110)
Accounts payable, accrued expenses and other liabilities (10,356) (15,644)
Net cash provided by operating activities 190,241 177,451
Cash flows from investing activities:    
Capital expenditures (33,124) (18,755)
Payments for acquisition of a business, net of cash acquired (6,545) (993,210)
Purchases of investments (24,250) 0
Proceeds from insurance settlements 0 654
Net cash used in investing activities (63,919) (1,011,311)
Cash flows from financing activities:    
Proceeds from the issuance of long-term debt 0 600,000
Principal payments on long-term debt (37,000) 0
Payment of Promissory Note (40,000) 0
Payments for financing costs 0 (9,266)
Deemed repurchases of restricted stock/units (14,320) (17,804)
Proceeds from stock option exercises 1,031 925
Excess tax benefits from share-based compensation arrangements 4,038 4,708
Principal payments on capital lease obligations (1,449) (1,312)
Distributions to noncontrolling member (3,154) 0
Contributions from noncontrolling member 1,373 835
Net cash (used in) provided by financing activities (89,481) 578,086
Net increase (decrease) in cash and cash equivalents from continuing operations 36,841 (255,774)
Cash flows from discontinued operations    
Net cash used in operating activities 0 (2,719)
Net decrease in cash and cash equivalents from discontinued operations 0 (2,719)
Effect of exchange rate changes on cash and cash equivalents 2,852 20,534
Cash and cash equivalents at beginning of period 201,367 521,951
Cash and cash equivalents at end of period $ 241,060 $ 283,992